LISTEN: Tens of thousands of people have filed claims for compensation from pharmaceutical companies accused of fueling the opioid crisis. But few have actually gotten a check. On May 28, WAMU’s “Health Hub” featured KFF Health News senior correspondent Aneri Pattani, who explained why some survivors feel like the money isn’t going to the right places.

Billions of dollars from opioid settlements are being paid out by drug manufacturers, distributors, and retailers to address the overdose crisis. Most of this money is landing in the hands of state and local governments to support public health initiatives such as housing, prevention, and access to treatment. But the lack of direct compensation for people affected by the overdose crisis has left many survivors feeling sidelined.

KFF Health News senior correspondent Aneri Pattani appeared on WAMU’s “Health Hub” on May 28 to explain why governments are facing pressure to use this windfall effectively to save lives and address the ongoing opioid crisis.

KFF Health News audio producers Zach Dyer and Taylor Cook contributed reporting to this segment.

KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF—an independent source of health policy research, polling, and journalism. Learn more about KFF.

USE OUR CONTENT

This story can be republished for free (details).



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Nicotine pouches helped me quit vaping – but now I’m addicted

‘I started nicotine pouches to get off vapes, but it’s just another addiction’ Hayley Jarvis BBC Scotland News Johnpaul began using nicotine pouches to help him get off vapes –

Trump’s Health Fraud Focus at Odds With Past Pardons

Since returning to the White House, President Donald Trump has made combating fraud a centerpiece of his administration. Trump has said he will target fraud in Medicare, Medicaid, and Social

Watch: GOP Senator Says Trump’s Tariffs Could Mean Safer Drugs — For a Price

President Donald Trump’s proposed tariffs on imported generic drugs could raise some prices for patients, a key GOP lawmaker on health issues said this week. But he said that’s a